CLEAR CELL SARCOMA (CCS)
Clinical trials for CLEAR CELL SARCOMA (CCS) explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL SARCOMA (CCS) trials appear
Sign up with your email to follow new studies for CLEAR CELL SARCOMA (CCS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted therapy trial offers hope for rare, aggressive cancer
Disease control Recruiting nowThis study is testing an immunotherapy drug called tebentafusp in people with advanced clear cell sarcoma, a rare and aggressive cancer. The trial is for patients who have a specific genetic marker (HLA-A*02:01) and whose cancer cannot be removed by surgery or has spread. Partici…
Matched conditions: CLEAR CELL SARCOMA (CCS)
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug trial targets rare, aggressive sarcoma
Disease control Recruiting nowThis study is testing an oral drug called vebreltinib for people with advanced clear cell sarcoma, a rare and aggressive cancer. It aims to see if the drug can shrink tumors and control the disease. The trial will enroll about 30 patients and compare their outcomes to a group rec…
Matched conditions: CLEAR CELL SARCOMA (CCS)
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC